News
A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for urinary tract infections, throws Escherichia ...
ABSTRACT: Gene editing technology, which allows for precise modifications to an organism’s genome, has emerged as a transformative tool in genetic engineering. This review introduces the fundamental ...
The study was published in Nature Microbiology on May 27, 2025. Morbilliviruses are highly contagious viruses that cause serious diseases in humans and animals. Prominent examples include measles ...
‘I’m polyamorous – this is how we manage our money’ Thousands of veterans to march on DC over benefits cuts—"Will not stand by" A couple who worked in the Maldives and Bali share how ...
Hosted on MSN1mon
Examining Nature Under the Microscope | Amazing DiscoveriesSee the Birch Glacier collapse: Swiss village buried after huge landslide Movies Over 4 Hours That Are Worth Every Minute Argentine court declares a mistrial in the death of soccer star Maradona ...
ABSTRACT: The prevalence of multi-drug resistant (MDR) Gram-negative bacteria has emerged as a significant public health concern, particularly among outpatients. In low-income countries like Zambia, ...
The novel findings are published in the current issue of Nature Microbiology. In recent years, the World Health Organization (WHO) has repeatedly warned of the increase in microbes resistant to ...
The novel findings are published in the current issue of Nature Microbiology. In recent years, the World Health Organization (WHO) has repeatedly warned of the increase in microbes resistant to ...
The finding, published today in Nature Microbiology, may be the impetus for new approaches in developing therapeutics against some of the world’s deadliest bacteria. It also validates a new use ...
The discovery, published today (March 21) in Nature Microbiology, could lead to new strategies for treating some of the deadliest bacterial infections. It also highlights a new use for a system ...
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) has announced the publication of preclinical data on CD388, its investigational drug-Fc conjugate (DFC) for influenza, in Nature Microbiology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results